Skip to main content
SpringerLink
Log in

Epidemiology and Socioeconomics of Reflux Disease

  • Chapter
  • First Online:
Antireflux Surgery

Abstract

Gastroesophageal reflux disease (GERD) and its many manifestations are common in North America and Europe. Although less common in Asia, Middle East, Caribbean, and African countries, its prevalence is increasing in these regions as well. Although the incidence of new cases is relatively low, the disease persists over long periods of time, thereby leading to an overall high prevalence. Risk factors include age, gender, ethnicity, obesity, physiologic/anatomic conditions, and lifestyle. GERD is an economic burden to patients, healthcare systems, employers, and society. Barrett’s esophagus is one of the more serious consequences of GERD. Its primary importance is as a risk factor for esophageal adenocarcinoma. Although prevalence and incidence of Barretts is difficult to determine, it is probably more common than initially believed. Risk factors are similar to GERD, although diet may play an additional role.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sobieraj DM, Coleman SM, Coleman CI. US prevalence of upper gastrointestinal symptoms: A systematic review. Am J Mang Care. 2011;17:e449–45.

    Google Scholar 

  2. Watson DI, Lally CJ. Prevalence of symptoms and use of medication for gastroesophageal reflux disease in an Australian community. World J Surg. 2009;33:88–94.

    Article  PubMed  Google Scholar 

  3. Fedorak RN, Veldhuyzen van Zanten S, Bridges R. Canadian Digestive Health Foundation Public Impact Series: gastroesophageal reflux disease in Canada: incidence, prevalence, and direct and indirect economic impact. Can J Gastroenterol. 2010;24:431–4.

    PubMed Central  PubMed  Google Scholar 

  4. Yuen E, Romney M, Toner RW, et al. Prevalence, knowledge and care patterns for gastro-oesophageal reflux disease in United States minority populations. Aliment Pharmacol Ther. 2010;32:645–54.

    CAS  PubMed  Google Scholar 

  5. Gisbert JP, Cooper A, Karagiannis D, et al. Consultation rates and characteristics of gastro-oesophagel reflux disease in primary care: a European observational study. Eur J Gen Pract. 2009;15:154–60.

    Article  PubMed  Google Scholar 

  6. Fletcher KC, Goutte M, Slaughter JC, et al. Significance and degree of reflux in patients with primary extraesophageal symptoms. Laryngoscope. 2011;121:2561–5.

    Article  PubMed  Google Scholar 

  7. Ford AC, Suares NC, Talley NJ. Meta-analysis: the epidemiology of noncardiac chest pain in the community. Aliment Pharmacol Ther. 2011;34:172–80.

    Article  CAS  PubMed  Google Scholar 

  8. Jaspersen D, Kulig M, Labenz J, et al. Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD study. Aliment Pharmacol Ther. 2003;17:1515–20.

    Article  CAS  PubMed  Google Scholar 

  9. Fass R, Dickman R. Clinical consequences of silent gastroesophageal reflux disease. Curr Gastroenterol Rep. 2006;8:195–201.

    Article  PubMed  Google Scholar 

  10. Goh K-L, Shiaw-Hooi H. Silent gastroesophageal disease: clinical implications of an unknown disease. J Gastroenterol Hepatol. 2011;26:941–2.

    Article  PubMed  Google Scholar 

  11. Wang PC, Hsu CS, Tseng TC, et al. Male sex, hiatus hernia, and Helicobacter pylori infection associated with asymptomatic erosive esophagitis. J Gastroenterol Hepatol. 2012;27:586–91.

    Article  PubMed  Google Scholar 

  12. Ronkainen J, Talley NJ, Storskrubb T, et al. Erosive esophagitis is a risk factor for Barrett’s esophagus: a community-based endoscopic follow-up study. Am J Gastroenterol. 2011;106:1946–52.

    Article  PubMed  Google Scholar 

  13. Labenz J, Nocon M, Lind T, et al. Prospective follow-up data from the ProGERD study suggest that GERD is not a categorical disease. Am J Gastroenterol. 2006;101:2457–62.

    Article  PubMed  Google Scholar 

  14. Malfertheiner P, Nocon M, Vieth M, et al. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care—the ProGERD study. Aliment Pharmacol Ther. 2012; 35:154–64.

    Article  CAS  PubMed  Google Scholar 

  15. El-Serag H, Hill C, Jones R. Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research Database. Aliment Pharmacol Ther. 2009;29:470–80.

    Article  CAS  PubMed  Google Scholar 

  16. Armstrong D. Systematic review: persistence and severity in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2008;28:841–53.

    CAS  PubMed  Google Scholar 

  17. Hansen JM, Wildner-Christensen M, Schaffalizky de Muckadell OB. Gastroesophageal reflux symptoms in a Danish population: a prospective follow-up analysis of symptoms, quality of life, and health-care use. Am J Gastroenterol. 2009;104:2394–403.

    Article  PubMed  Google Scholar 

  18. Ageing reference

    Google Scholar 

  19. Menon S, Trudgill N. Risk factors in the aetiology of hiatus hernia: a meta-analysis. Eur J Gastroenterol Hepatol. 2011;23:133–8.

    Article  PubMed  Google Scholar 

  20. Chen Z, Thompson SK, Jamieson GG, et al. Effect of sex on symptoms associated with gastroesophageal reflux. Arch Surg. 2011; 146:1164–9.

    Article  PubMed  Google Scholar 

  21. Kang JY. Systematic review: geographical and ethnic differences in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2004;20:705–17.

    Article  CAS  PubMed  Google Scholar 

  22. Friedenberg FK, Rai J, Vanar V, et al. Prevalence and risk factors for gastroesophageal reflux disease in an impoverished minority population. Obes Res Clin Pract. 2010;4:e261–369.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol. 2011;8:340–7.

    Article  PubMed  Google Scholar 

  24. Sonnenberg A. Effects of environment and lifestyle on gastroesophageal reflux disease. Dig Dis. 2011;29:229–34.

    Article  PubMed  Google Scholar 

  25. Gao L, Weck MN, Rothenbacher D, Brenner H. Body mass index, chronic atrophic gastritis and heartburn: a population-based study among 8936 older adults from Germany. Aliment Pharmacol Ther. 2010;32:296–302.

    Article  CAS  PubMed  Google Scholar 

  26. Lofdahl HE, Lane A, Lu Y, et al. Increased population prevalence of reflux and obesity in the United Kingdom compare with Sweden: a potential explanation for the difference in incidence of esophageal adenocarcinoma. Eur J Gastroenterol Hepatol. 2011;23:128–32.

    Article  PubMed  Google Scholar 

  27. Savarino E, Zentilin P, Marabotto E, et al. Overweight is a risk factor for both erosive and non-erosive reflux disease. Dig Liver Dis. 2011;43:940–5.

    Article  PubMed  Google Scholar 

  28. Fujiwara Y, Kubo M, Kohata Y, et al. Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia or irritable bowel syndrome. Intern Med. 2011; 50:2443–7.

    Article  PubMed  Google Scholar 

  29. Gaddam S, Maddur H, Wani S, et al. Risk factors for nocturnal reflux in a large GERD cohort. J Clin Gastroenterol. 2011; 45:764–8.

    Article  PubMed  Google Scholar 

  30. Martin-Merino E, Ruigomez A, Garcia-Rodriguez LA, et al. Depression and treatment with antidepressants are associated with the development of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2010;31:1132–40.

    CAS  PubMed  Google Scholar 

  31. Imagama S, Hasegawa Y, Wakao N, et al. Influence of lumbar kyphosis and back muscle strength on the symptoms of gastroesophageal reflux disease in middle-aged and elderly people. Eur Spine J. 2012; Feb 28 [Epub ahead of print]

    Google Scholar 

  32. Kim N, Lee SW, Baik GH, et al. Effect of Helicobacter pylori eradication on the development of reflux esophagitis and gastroesophageal reflux symptoms: a nationwide multi-center prospective study. Gut Liver. 2011;5:437–46.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Li J, Brackbill RM, Stellman SD, et al. Gastroesophageal reflux symptoms and comorbid asthma and posttraumatic stress disorder following the 9/11 terrorist attacks on World Trade Center in New York City. Am J Gastroenterol. 2011;106:1933–41.

    Article  PubMed  Google Scholar 

  34. Velanovich V. The effects of chronic pain syndromes and psycho-emotional disorders on symptomatic and quality of life outcomes of antireflux surgery. J Gastrointest Surg. 2003;7:53–8.

    Article  PubMed  Google Scholar 

  35. Wagner JS, DiBonaventura MD, Balu S, Buchner D. The burden of diurnal and nocturnal gastroesophageal reflux disease symptoms. Expert Rev Pharmacoecon Outcomes Res. 2011;11:739–49.

    Article  PubMed  Google Scholar 

  36. Gisbert JP, Cooper A, Karagiannis D, et al. Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study. Health Qual Life Outcomes. 2009;7:90.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Wahlqvist P, Karlsson M, Johnson D, et al. Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort. Aliment Pharmacol Ther. 2008;27:960–70.

    Article  CAS  PubMed  Google Scholar 

  38. Toghanian S, Johnson DA, Stalhammar NO, Zerbib F. Burdent of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: a post hoc analysis of the 2007 National Health and Wellness Survey. Clin Drug Investig. 2011;31:703–15.

    Article  CAS  PubMed  Google Scholar 

  39. Darba J, Kaskens L, Plans P, et al. Epidemiology and societal costs of gastroesophageal reflux disease and Barrett’s syndrome in Germany, Italy and Spain. Expert Rev Pharmacoecon Outcomes Res. 2011;11:225–32.

    Article  PubMed  Google Scholar 

  40. Gerson L, McLaughlin T, Balu S, et al. Variation of health-care resource utilization according to GERD-associated complications. Dis Esophagus 2012; Jan 31 [Epub ahead of print]

    Google Scholar 

  41. Jayadevappa R, Chhatre S, Weiner M. Gastro-oesophageal acid-related disease, co-morbidity and medical care cost. Chronic Illn. 2008;4:209–18.

    Article  PubMed  Google Scholar 

  42. Thukkani N, Sonnenberg A. The influence of environmental risk factors in hospitalization for gastro-oesophageal reflux disease-related diagnoses in the United States. Aliment Pharmacol Ther. 2010;31:852–61.

    CAS  PubMed  Google Scholar 

  43. Gosselin A, Luo R, Lohouses H, et al. The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease. Value Health. 2009;12:34–9.

    Article  PubMed  Google Scholar 

  44. Raman A, Sternbach J, Babajide A, et al. When does testing for GERD become cost effective in an integrated health network? Surg Endosc. 2010;24:1245–9.

    Article  PubMed  Google Scholar 

  45. Epstein D, Bojke L, Sculpher MJ, The REFLUX trial group. Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study. BMJ. 2009;339:b2576.

    Article  PubMed Central  PubMed  Google Scholar 

  46. Wang KK, Sampliner RE, Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103:788–97.

    Article  PubMed  Google Scholar 

  47. Spechler SJ. Clinical practice. Barrett’s esophagus. N Engl J Med. 2002;346:836–42.

    Article  PubMed  Google Scholar 

  48. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825–31.

    Article  PubMed  Google Scholar 

  49. Westhoff B, Brotze S, Weston A, et al. The frequency of Barrett’s esophagus in high-risk patients with chronic GERD. Gastrointest Endosc. 2005;61:226–31.

    Article  PubMed  Google Scholar 

  50. Dickman R, Kim JL, Camargo L, et al. Correlation of gastroesophageal reflux disease symptom characteristics with long-segment Barrett’s esophagus. Dis Esophagus. 2006;19:360–5.

    Article  CAS  PubMed  Google Scholar 

  51. Cameron AJ. Epidemiology of Barrett’s esophagus and adenocarcinoma. Dis Esophagus. 2002;15:106–8.

    Article  CAS  PubMed  Google Scholar 

  52. Guardino JM, Khandwala F, Lopez R, et al. Barrett’s esophagus at a tertiary care center: association of age on incidence and prevalence of dysplasia and adenocarcinoma. Am J Gastroenterol. 2006;101:2187–93.

    Article  PubMed  Google Scholar 

  53. Cook MB, Shaheen NJ, Anderson LA, et al. Cigarette smoking increases risk of Barrett’s esophagus: An analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium. Gastroenterology 2012; Jan 11 [Epub ahead of print]

    Google Scholar 

  54. Kubo A, Block G, Queensberry Jr CP, et al. Effects of dietary fiber, fats, and meat intakes on the risk of Barrett’s esophagus. Nutr Cancer. 2009;61:607–16.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of South Florida, One Tampa General Circle, F145, Tampa, FL, 33606, USA

    Vic Velanovich MD

Authors
  1. Vic Velanovich MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vic Velanovich MD .

Editor information

Editors and Affiliations

  1. GI and MIS Surgery, The Oregon Clinic Providence Portland Medical Center, Portland, Oregon, USA

    Lee L. Swanstrom

  2. GI and MIS Surgery, The Oregon Clinic Providence Portland Medical Center, Portland, Oregon, USA

    Christy M. Dunst

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer New York

About this chapter

Cite this chapter

Velanovich, V. (2015). Epidemiology and Socioeconomics of Reflux Disease. In: Swanstrom, L., Dunst, C. (eds) Antireflux Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1749-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1749-5_3

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1748-8

  • Online ISBN: 978-1-4939-1749-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation